What questions prevent surprise fees in a GLP-1 program paid through Medicare?

Ask about your Part D plan's formulary, prior authorization rules, drug indication, and your costs during each coverage phase, including the 'donut hole'.

Confirm Your Diagnosis and the Drug's Indication

Medicare Part D coverage is strictly tied to a drug's FDA-approved indication. Historically, Medicare has been statutorily barred from covering medications solely for chronic weight management. Therefore, your specific diagnosis is the first and most critical factor determining coverage.

GLP-1 medications like Ozempic and Mounjaro are FDA-approved to treat type 2 diabetes, and Medicare Part D plans often cover them for this use. In contrast, Wegovy and Zepbound are approved for chronic weight management, which typically falls under the Part D exclusion.

However, recent FDA approval for Wegovy to reduce the risk of major adverse cardiovascular events in certain overweight or obese adults may allow for Part D coverage in specific cases. Ask your physician: "Is the GLP-1 you are prescribing FDA-approved for my specific diagnosis?"

Verify Your Part D Plan's Formulary

Even with a covered diagnosis, the specific GLP-1 drug must be on your Medicare Part D plan's formulary, which is its list of covered medications. Formularies vary significantly between different insurance providers and can change annually.

Drugs on the formulary are sorted into tiers, which determine your copayment or coinsurance. A GLP-1 agonist might be a 'non-preferred' brand drug (Tier 3 or 4) or a 'specialty' drug (Tier 5), carrying much higher out-of-pocket costs than generic medications.

Ask your insurance provider directly: "Is [Wegovy/Ozempic/Mounjaro] on my plan's formulary for this year? If so, what tier is it on, and what is the estimated copay?"

Understand Prior Authorization and Step Therapy

Most Part D plans require Prior Authorization (PA) for expensive brand-name drugs like GLP-1s. This means your physician must submit clinical documentation to the insurer to prove the medication is medically necessary before the plan will agree to pay for it.

The PA process may also include 'step therapy.' Your insurer might require you to first try and fail one or more less expensive, alternative medications (like metformin for type 2 diabetes) before they will approve coverage for a GLP-1 medication.

Ask your prescribing physician and insurer: "Does this medication require prior authorization? What are the specific clinical criteria for approval, and does my plan require step therapy first?"

Calculate Costs Across All Part D Coverage Phases

A major source of surprise fees is the Medicare Part D coverage gap, often called the 'donut hole'. Your out-of-pocket costs change as you move through four distinct phases: the deductible, initial coverage, the coverage gap, and catastrophic coverage.

Because brand-name GLP-1s can cost over $1,000 per month, you may meet your deductible and exit the initial coverage phase very quickly. Once in the coverage gap, you are responsible for 25% of the drug's cost until you reach the catastrophic coverage threshold.

Ask your Part D plan administrator: "Based on the cost of this drug, can you estimate my monthly out-of-pocket expense in each coverage phase and when I will likely enter the coverage gap?"

Plan for Denials and Explore Alternatives

If your request for coverage is denied, you have the right to a formal appeal. However, if coverage is not possible due to formulary exclusions or indication, you may need to consider other options. Manufacturer Patient Assistance Programs (PAPs) exist but often explicitly exclude Medicare beneficiaries.

For patients seeking GLP-1s for weight loss who do not have coverage, some may turn to physician-supervised programs that utilize compounded medications. These programs, such as GOAL.MD's medical weight loss program, are self-pay and operate outside of insurance.

It is critical to understand that compounded medications are prepared in licensed U.S. pharmacies but are not FDA-approved. As such, they are not covered by Medicare or any other insurance plan. This path avoids insurance complexity but involves paying the full cost of the program directly.

Bottom Line

Navigating Medicare for GLP-1 coverage is complex and fraught with potential surprise costs. Coverage hinges entirely on your diagnosis, the specific drug prescribed, and the fine print of your Part D plan, including its formulary, prior authorization rules, and cost-sharing structure.

Proactively asking detailed questions about your plan's formulary, the prior authorization process, and how costs will change as you enter the coverage gap is the best strategy to prevent unexpected fees. Diligence before filling your first prescription is key.

This information is for educational purposes only and does not constitute medical advice. Consult with your healthcare provider for personalized guidance.

Drafted by the GOAL.MD Authority Engine and approved editorially by GOAL.MD staff. This page has not received its own physician review. Physician-supervised telehealth. More at goal.md/answers.